Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan vs Enalapril in Essential Hypertension
NCT02177448Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 1998
- Primary completion
- Sep 1999
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of telmisartan in essential hypertension, sponsored by Boehringer Ingelheim. Started Sep 1998; status: completed.
02
Drugs
telmisartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT02177448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02177448.